Sources
Loading...
Additional media
Loading...
Grifols, a Spanish pharmaceutical company, is reportedly being targeted for a $6 billion takeover bid by its founding family and Brookfield Capital Partners. The potential deal aims to delist Grifols, with details of the acquisition still undisclosed.
The family that owns Spanish #pharma Grifols and private equity firm @Brookfield may take the company private in a deal worth around €5.5bn. $GRF https://t.co/11FLpiA8h3
Grifols says founding family, Brookfield looking to delist Spanish drugmaker https://t.co/YCiZDpAEwE
Troubled Spanish pharma company Grifols says it may go private for $6 billion https://t.co/WbCYx46GFn